Search

Melody Noel Brown

Examiner (ID: 10713, Phone: (571)272-2599 , Office: P/2917 )

Most Active Art Unit
2917
Art Unit(s)
2911, 2901, 2915, 2917
Total Applications
11779
Issued Applications
11665
Pending Applications
10
Abandoned Applications
102

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 10154620 [patent_doc_number] => 09186373 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-17 [patent_title] => 'SiRNA against Cbl-b and optionally IL-2 and IL-12 for use in the treatment of cancer' [patent_app_type] => utility [patent_app_number] => 13/977453 [patent_app_country] => US [patent_app_date] => 2011-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 7853 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13977453 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/977453
SiRNA against Cbl-b and optionally IL-2 and IL-12 for use in the treatment of cancer Dec 26, 2011 Issued
Array ( [id] => 9281444 [patent_doc_number] => 20140031412 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-30 [patent_title] => 'METHOD OF TREATMENT' [patent_app_type] => utility [patent_app_number] => 13/996984 [patent_app_country] => US [patent_app_date] => 2011-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16639 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13996984 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/996984
Method of treatment Dec 19, 2011 Issued
Array ( [id] => 10123565 [patent_doc_number] => 09157919 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-10-13 [patent_title] => 'Method for identifying biologically active oligonucleotides capable of modulating the immune system' [patent_app_type] => utility [patent_app_number] => 13/995304 [patent_app_country] => US [patent_app_date] => 2011-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 31 [patent_no_of_words] => 12739 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13995304 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/995304
Method for identifying biologically active oligonucleotides capable of modulating the immune system Dec 19, 2011 Issued
Array ( [id] => 9122177 [patent_doc_number] => 20130289099 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-31 [patent_title] => 'ABCG1 GENE AS A MARKER AND A TARGET GENE FOR TREATING OBESITY' [patent_app_type] => utility [patent_app_number] => 13/993726 [patent_app_country] => US [patent_app_date] => 2011-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 14042 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13993726 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/993726
ABCG1 GENE AS A MARKER AND A TARGET GENE FOR TREATING OBESITY Dec 15, 2011 Abandoned
Array ( [id] => 9597786 [patent_doc_number] => 20140194467 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-10 [patent_title] => 'PLASMA CELL DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/993834 [patent_app_country] => US [patent_app_date] => 2011-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11083 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13993834 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/993834
PLASMA CELL DISORDERS Dec 12, 2011 Abandoned
Array ( [id] => 10162759 [patent_doc_number] => 09193973 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-24 [patent_title] => 'Compositions and methods for increasing erythropoietin (EPO) production' [patent_app_type] => utility [patent_app_number] => 13/992334 [patent_app_country] => US [patent_app_date] => 2011-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 27 [patent_no_of_words] => 53365 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 180 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13992334 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/992334
Compositions and methods for increasing erythropoietin (EPO) production Dec 8, 2011 Issued
Array ( [id] => 9223635 [patent_doc_number] => 20140018410 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-16 [patent_title] => 'COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF KLF-1 AND BCL11A GENES' [patent_app_type] => utility [patent_app_number] => 13/992669 [patent_app_country] => US [patent_app_date] => 2011-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 52685 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13992669 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/992669
Compositions and methods for inhibiting expression of klf-1 and bcl11a genes Dec 8, 2011 Issued
Array ( [id] => 9004536 [patent_doc_number] => 20130225661 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-29 [patent_title] => 'Inhibitors Of SP140 And Their Use In Therapy' [patent_app_type] => utility [patent_app_number] => 13/883091 [patent_app_country] => US [patent_app_date] => 2011-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 12585 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13883091 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/883091
Inhibitors of SP140 and their use in therapy Nov 22, 2011 Issued
Array ( [id] => 9122176 [patent_doc_number] => 20130289098 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-31 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATMENT OF OVARIAN CANCER' [patent_app_type] => utility [patent_app_number] => 13/977797 [patent_app_country] => US [patent_app_date] => 2011-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13801 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13977797 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/977797
Compositions and methods for treatment of ovarian cancer Nov 19, 2011 Issued
Array ( [id] => 9295400 [patent_doc_number] => 20140039035 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-06 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING OBESITY' [patent_app_type] => utility [patent_app_number] => 13/988095 [patent_app_country] => US [patent_app_date] => 2011-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 15899 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13988095 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/988095
COMPOSITIONS AND METHODS FOR TREATING OBESITY Nov 17, 2011 Abandoned
Array ( [id] => 9206075 [patent_doc_number] => 20140005252 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-02 [patent_title] => 'MODULATION OF ALPHA SYNUCLEIN EXPRESSION' [patent_app_type] => utility [patent_app_number] => 13/988296 [patent_app_country] => US [patent_app_date] => 2011-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26971 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13988296 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/988296
Modulation of alpha synuclein expression Nov 16, 2011 Issued
Array ( [id] => 9042461 [patent_doc_number] => 20130245099 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-19 [patent_title] => 'ANTAGONAT COMPOSITIONS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 13/988063 [patent_app_country] => US [patent_app_date] => 2011-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 16484 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13988063 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/988063
Antagonat compositions and methods of use Nov 16, 2011 Issued
Array ( [id] => 10608324 [patent_doc_number] => 09328346 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-03 [patent_title] => 'Polycomb-associated non-coding RNAs' [patent_app_type] => utility [patent_app_number] => 13/884670 [patent_app_country] => US [patent_app_date] => 2011-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 68 [patent_no_of_words] => 62375 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13884670 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/884670
Polycomb-associated non-coding RNAs Nov 11, 2011 Issued
Array ( [id] => 10863951 [patent_doc_number] => 08889649 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-18 [patent_title] => 'Composition containing antisense oligonucleotide to micro RNA' [patent_app_type] => utility [patent_app_number] => 13/884436 [patent_app_country] => US [patent_app_date] => 2011-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8668 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13884436 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/884436
Composition containing antisense oligonucleotide to micro RNA Nov 9, 2011 Issued
Array ( [id] => 9206073 [patent_doc_number] => 20140005250 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-02 [patent_title] => 'Compositions and Methods for Increasing Drug Efficacy in Cancer' [patent_app_type] => utility [patent_app_number] => 13/883862 [patent_app_country] => US [patent_app_date] => 2011-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 15796 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13883862 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/883862
Compositions and methods for increasing drug efficacy in cancer Nov 6, 2011 Issued
Array ( [id] => 8707497 [patent_doc_number] => 20130064786 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-14 [patent_title] => 'siRNA HYDROGEL AND METHOD FOR MANUFACTURING THE SAME' [patent_app_type] => utility [patent_app_number] => 13/288167 [patent_app_country] => US [patent_app_date] => 2011-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5048 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13288167 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/288167
SiRNA hydrogel and method for manufacturing the same Nov 2, 2011 Issued
Array ( [id] => 9331188 [patent_doc_number] => 20140057970 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-27 [patent_title] => 'Use of Hepcidin Binding Nucleic Acids for Depletion of Hepcidin From the Body' [patent_app_type] => utility [patent_app_number] => 13/882197 [patent_app_country] => US [patent_app_date] => 2011-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 43262 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13882197 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/882197
Use of Hepcidin Binding Nucleic Acids for Depletion of Hepcidin From the Body Oct 30, 2011 Abandoned
Array ( [id] => 8172203 [patent_doc_number] => 20120107825 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-03 [patent_title] => 'METHODS AND COMPOSITIONS FOR ASSESSING PATIENTS WITH REPRODUCTIVE FAILURE USING IMMUNE CELL-DERIVED MICRORNA' [patent_app_type] => utility [patent_app_number] => 13/284739 [patent_app_country] => US [patent_app_date] => 2011-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 21598 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20120107825.pdf [firstpage_image] =>[orig_patent_app_number] => 13284739 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/284739
METHODS AND COMPOSITIONS FOR ASSESSING PATIENTS WITH REPRODUCTIVE FAILURE USING IMMUNE CELL-DERIVED MICRORNA Oct 27, 2011 Abandoned
Array ( [id] => 9042458 [patent_doc_number] => 20130245096 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-19 [patent_title] => 'COMPOSITIONS AND METHODS FOR ACTIVATING EXPRESSION BY A SPECIFIC ENDOGENOUS miRNA' [patent_app_type] => utility [patent_app_number] => 13/881350 [patent_app_country] => US [patent_app_date] => 2011-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 30269 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13881350 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/881350
COMPOSITIONS AND METHODS FOR ACTIVATING EXPRESSION BY A SPECIFIC ENDOGENOUS miRNA Oct 26, 2011 Abandoned
Array ( [id] => 9095006 [patent_doc_number] => 20130274317 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-17 [patent_title] => 'DERIVATIVES OF SMALL INTERFERING RNAS AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/883081 [patent_app_country] => US [patent_app_date] => 2011-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7906 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13883081 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/883081
DERIVATIVES OF SMALL INTERFERING RNAS AND USE THEREOF Oct 25, 2011 Abandoned
Menu